Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Moberg Pharma Major Shareholding Notification 2019

Sep 13, 2019

3174_iss_2019-09-13_f2bc9452-d18c-42c9-84be-798316bf4206.pdf

Major Shareholding Notification

Open in viewer

Opens in your device viewer

Issuer Moberg Pharma AB (publ)

Holder

Armistice Capital LLC (Delaware US LLC)

Instrument

Instrument Shares
Before the transaction
Shares Data not given*
Voting rights Data not given*
Transaction
Reason for major shareholding notification Sell
Date 01/04/2019
Limit for number of shares 5 %
Limit for number of votes 5 %
After the transaction
Quantity
Shares 853,458
Directly held voting rights 0
Indirectly held voting rights 853,458
Percentage
Directly held shares 4.98989 %
Directly held voting rights 0 %
Indirectly held voting rights 4.98989 %

Resulting distribution of total holdings

Percentage of voting
rights:
Number of underlying
shares:
Shares 4.98989 % 853,458
Instruments - FITA Ch. 4, section 2, first
paragraph, line 2
Instruments - FITA Ch. 4, section 2,
first paragraph, line 3
- Physically settled
- Cash settled
Total 4.98989 % 853,458
Chain
of
controlling
companies
Voting rights % Voting rights Company
853,458
4.98989
Armistice Capital Master Fund Ltd
Group
total
holdings
Voting rights
853,458
Percentage of voting rights 4.98989
Published
13/09/2019 14:01
Contact
Name
Daniel Radden
Phone
212 231-4937 Email [email protected]

*Source of information has chosen not to submit the data

CLOSE PRINT

[email protected] Tfn 08-408 980 37 Fax 08-24 39 25